CLINICAL_TRIALS
other
· 2024-08-12
Clinical Trial Update: Gene Therapy Study for Children With CLN5 Batten Disease [Phase 1, Phase 2]
Summary
Gene therapy study for Neuronal Ceroid Lipofuscinosis CLN5 is currently active but not recruiting, spanning Phase 1 and Phase 2.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Neurogene Inc. | Conditions: Neuronal Ceroid Lipofuscinosis CLN5 | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING